Following the FDA ODD, European designation underscores ICT01’s potential as a novel immunotherapy approach in AML ...

Of 34 CMML treatment-naïve participants enrolled and treated with lenzilumab plus azacitidine, 22 have evaluable responses in the first twelve months of follow-up - Building upon previously reported ...

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...

A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...

Acute monocytic leukemia (AML-M5): Cancer develops in cells that make monocytes, a white blood cell. Acute megakaryocytic leukemia (AMLK): Affects cells responsible for red blood cells or platelets.

Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...

MUSC researchers at the Hollings Cancer center are making strides in new developments for leukemia treatment.Sophie Paczesny, ...

Panelists highlight that patient advocacy is crucial in improving high-risk acute myeloid leukemia (AML) outcomes by ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...

Bleeding gums need not always be associated with leukaemia however frequent bleeding in gums may be a sign of something more ...

Acute myeloid leukemia (AML) is rare in pregnancy, progresses fast, and needs to be treated. We explain symptoms, treatment, and outlook for AML in pregnancy.